Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-associated
100%
Risk Reduction
100%
National Cohort Study
100%
Inflammatory Bowel Disease
100%
Metformin Use
100%
Metformin
38%
Disease-free
23%
Anti-inflammatory Effect
15%
Gut Microbiome
15%
New User
15%
Odds Ratio
7%
Crohn's Disease
7%
Ulcerative Colitis
7%
Population-based Study
7%
Treatment Duration
7%
Disease Diagnosis
7%
Adjusted Odds Ratio
7%
Educational Level
7%
Statins
7%
Glucose-lowering Drugs
7%
Nested Case-control Study
7%
Conditional Logistic Regression
7%
Anti-inflammatory Properties
7%
Pleiotropic Effects
7%
Immune-mediated Inflammatory Diseases
7%
Dipeptidyl peptidase-4 (DPP-4)
7%
Cumulative Dose
7%
Ever Use
7%
Older Population
7%
Active Comparator
7%
Mathematics
Odds Ratio
100%
Microbiome
100%
Comparator
50%
Control Study
50%
Nested Case
50%
Conditional Logistic Regression
50%
Treatment Duration
50%
Biochemistry, Genetics and Molecular Biology
Microbiome
100%
Case-Control Study
50%
Statin
50%
Pleiotropy
50%
Antiinflammatory Activity
50%
Dipeptidyl Peptidase-4
50%
Medicine and Dentistry
Glycon
100%
Inflammatory Bowel Disease
100%
Odds Ratio
16%
Gut Microbiome
16%
Crohn's Disease
8%
Ulcerative Colitis
8%
Diagnosis
8%
Logistic Regression Analysis
8%
Case-Control Study
8%
Inflammatory Disorder
8%
Statin
8%
Anti-Inflammatory Drug
8%
Treatment Duration
8%
Antiinflammatory Activity
8%
Patient with Inflammatory Bowel Disease
8%
Dipeptidyl Peptidase-4 Inhibitor
8%
Pleiotropy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Inflammatory Bowel Disease
100%
Microbiome
15%
Ulcerative Colitis
7%
Case-Control Study
7%
Inflammatory Disease
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Crohn's Disease
7%
Anti-Inflammatory Drug
7%
Antiinflammatory Activity
7%
Dipeptidyl Peptidase IV Inhibitor
7%
Neuroscience
Inflammatory Bowel Disease
100%
Metformin
100%
Anti-Inflammatory
15%
Statin
7%
Dipeptidyl Peptidase-4 Inhibitor
7%